John Samuel will resume as executive chairman until a full-time chief executive is appointed
Tissue Regenix PLC’s () chief executive Steve Cauldwell is to step down permanently after a recurrence of the illness that kept him away from January to June.
John Samuel will resume as executive chairman until a full-time chief executive is appointed while current COO Gareth Jones will become interim- CEO.
Cauldwell said: “ The company is at such an exciting point of commercial and operational inflection and I remain committed to being available as an adviser and mentor wherever possible."
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Tissue Regenix Group PLC named herein, including the promotion by the Company of Tissue Regenix Group PLC in any Content on the Site, the...
FOR OUR FULL DISCLAIMER CLICK HERE